Value of FIB-4 and NAFLD fibrosis scores for screening of liver fibrosis in the general population

被引:0
|
作者
Graupera, Isabel [1 ]
Serra-Burriel, Miquel [2 ]
Thiele, Maja [3 ]
Caballeria, Llorenc [4 ]
Roulot, Dominique [5 ]
Wong, Grace Lai-Hung [6 ]
Fabrellas, Nuria [7 ]
Guha, Neil [8 ]
Arslanow, Anita [9 ]
Exposito, Carmen [4 ]
Hernandez, Rosario [10 ]
Aithal, Guruprasad [8 ]
Galle, Peter [9 ]
Wong, Vincent Wai-Sun [6 ]
Lammert, Frank [11 ]
Gines, Pere [1 ]
Laurent, Castera [12 ]
Krag, Aleksander [3 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain
[2] Univ Pompeu Fabra, Ctr Res Hlth & Econ, Barcelona, Spain
[3] Univ Southern Denmark, Liver Res Ctr, Odense, Denmark
[4] Inst Univ Invest Atencio Primaria IDIAP Jordi Gol, ICS Metropolitana Nord, Mataro, Spain
[5] Hop Avicenne, APHP, Bobigny, France
[6] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[7] Univ Barcelona, Sch Nursing, Barcelona, Spain
[8] Univ Nottingham Univ Hosp, Queens Med Ctr, Nottingham, England
[9] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Klin 2, Mainz, Germany
[10] Inst Cat Salut, CAP MARINA, Barcelona, Spain
[11] Univ Clin Saarland, Fac Med, Homburg, Germany
[12] Hop Beaujon, Hepatol, Clichy, France
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI030
引用
收藏
页码:S414 / S415
页数:2
相关论文
共 50 条
  • [1] Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
    Graupera, Isabel
    Thiele, Maja
    Serra-Burriel, Miquel
    Caballeria, Llorenc
    Roulot, Dominique
    Wong, Grace Lai-Hung
    Fabrellas, Nuria
    Guha, Indra Neil
    Arslanow, Anita
    Exposito, Carmen
    Hernandez, Rosario
    Aithal, Guruprasad Padur
    Galle, Peter R.
    Pera, Guillem
    Wong, Vincent Wai-Sun
    Lammert, Frank
    Gines, Pere
    Castera, Laurent
    Krag, Aleksander
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (11) : 2567 - +
  • [2] Reply to: Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population
    van Kleef, Laurens A.
    Sonneveld, Milan J.
    de Knegt, Robert J.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (01) : 238 - 239
  • [3] Suboptimal reliability of FIB-4 and NAFLD-fibrosis scores for staging of liver fibrosis in general population
    Hazzan, Rawi
    Abu Ahmad, Nur
    Habib, Abu Shqara
    Saleh, Igbaria
    Ziv, Neeman
    [J]. JGH OPEN, 2024, 8 (02):
  • [4] FIB-4 AND NAFLD FIBROSIS SCORES ARE POOR PREDICTORS FOR LIVER FIBROSIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Barbara, Mary
    Alkhouri, Naim
    Hashim, Mahmoud
    Hassan, Manal M.
    Jalal, Prasun K.
    [J]. HEPATOLOGY, 2020, 72 : 915A - 916A
  • [5] Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
    Kjaergaard, Maria
    Lindvig, Katrine Prier
    Thorhauge, Katrine Holtz
    Andersen, Peter
    Hansen, Johanne Kragh
    Kastrup, Nanna
    Jensen, Jane Moller
    Hansen, Camilla Dalby
    Johansen, Stine
    Israelsen, Mads
    Torp, Nikolaj
    Trelle, Morten Beck
    Shan, Shan
    Detlefsen, Soenke
    Antonsen, Steen
    Anderson, Jorgen Ellegaard
    Graupera, Isabel
    Gines, Pere
    Thiele, Maja
    Krag, Aleksander
    [J]. JOURNAL OF HEPATOLOGY, 2023, 79 (02) : 277 - 286
  • [6] Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population
    Rigor, Joana
    Diegues, Andreia
    Presa, Jose
    Barata, Pedro
    Martins-Mendes, Daniela
    [J]. POSTGRADUATE MEDICINE, 2022, 134 (04) : 435 - 440
  • [7] The value of APRI and FIB-4 scores in detection of liver fibrosis of patients with chronic hepatitis C
    Arikan, Hatice Burcu Acikalin
    Demirdal, Tuna
    Bilir, Neriman
    [J]. CUKUROVA MEDICAL JOURNAL, 2023, 48 (02): : 663 - 668
  • [8] Use of Fibrosis-4 (FIB-4) in liver fibrosis screening: which thresholds to choose?
    Ouzan, Denis
    Corneille, Jeremie
    Penaranda, Guillaume
    Dubertrand, Jean Marie
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S499 - S500
  • [9] SCREENING FOR HEPATIC FIBROSIS IN GENERAL PRACTICE BY FIB-4 SCORE, FOLLOWED IN SECOND LINE BY THE ELF (ENHANCED LIVER FIBROSIS) TEST: WHICH FIB-4 THRESHOLDS TO CHOOSE?
    Ouzan, Denis
    Penaranda, Guillaume
    Bournot, Franck
    Corneille, Jeremie
    [J]. HEPATOLOGY, 2022, 76 : S1051 - S1051
  • [10] Remogliflozin Etabonate Reduces FIB-4 and NAFLD Fibrosis Scores in Type 2 Diabetic Subjects
    Wilkison, Bill
    Cheatham, Bentley
    Walker, Susan
    [J]. HEPATOLOGY, 2016, 64 : 548A - 548A